Restraint of Trade: Does Manipulation of LIBOR Fall Within the Sherman Act’s Definition of Trade A Question of First Principles
Michael Eisenkraft, J. Douglas Richards, Nov 28, 2012
Defendants’ motions to dismiss the antitrust claims of the Plaintiffs in the LIBOR multi-district litigation includes an argument that advocates for a limitation on the coverage of Section 1 of the Sherman Act based on the assertion that LIBOR is not a traditional good traded in commerce. Defendants argue that the Sherman Act does not cover manipulation of U.S. LIBOR as this manipulation cannot constitute a restraint of trade because “LIBOR is just an index and not is itself a marketplace transaction.” Defendants’ motions to dismiss the antitrust claims of the Plaintiffs in the LIBOR multi-district litigation includes an argument that advocates for a limitation on the coverage of Section 1 of the Sherman Act based on the fact that LIBOR is not a traditional good traded in commerce. Defendants argue that the Sherman Act does not cover manipulation of U.S. LIBOR as this manipulation cannot constitute a restraint of trade because “LIBOR is just an index and not is itself a marketplace transaction.”…
From Plaintiffs’ perspective, Defendants’ arguments bear the usual indicia of an attempt to make new law-an absence of case citations supporting the core of an argument accompanied by rhetorical devices designed to indicate that the assertion they advocate is so simple and basic that common sense, as opposed to case law or other legal citations, is sufficient for them to prevail. From Defendants’ perspective, their argument’s lack of legal citations is a function of the novelty of Plaintiffs’ claims and not the novelty of their defense- according to Defendants, no court has ever had to rule on a claim precisely like this one because no plaintiff has ever brought an antitrust claim based on manipulation of an index that lies outside the marketplace and that is not attached to an underlying commodity.
Regardless of who is right-whether this is a novel defense, a novel claim, or both-what is relatively certain is that there is something here that merits comment, discussion, and study.
Links to Full Content
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh